CCM · NYSE · ·
$3.32-4.5%9月29日 終値
企業自身の 6-K から。
Concord Medical Services Holdings Limited is a healthcare provider featuring a full cycle of premium oncology services including cancer diagnosis, treatment, education and prevention. The Company focuses on providing multidisciplinary cancer care in all aspects of oncology healthcare services in its cancer hospitals and equipping them with technologically advanced equipment such as the state-of-the-art proton therapy system. The Company is striving to improve the quality and accessibility of cancer care through its network of self-owned cancer hospitals and clinics as well as partnered hospitals across China.
発表資料の末尾に記載された、企業自身による説明です。
引用と会社概要は、Concord Medical Services Holdings Ltd が 2025年9月26日 に提出した決算の 6-K からです。表は同社の四半期報告書に基づきます。 EDGAR で発表資料を読む 株価は分割と配当で調整済みです。
Concord Medical Services Holdings Ltd の決算説明会の書き起こしはありません。